BlackRock Inc. acquired a new position in shares of American Vanguard Corporation (NYSE:AVD - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 933,473 shares of the basic materials company's stock, valued at approximately $2,614,000. BlackRock Inc. owned 3.26% of American Vanguard at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. R Squared Ltd purchased a new position in American Vanguard in the first quarter valued at about $28,000. Strs Ohio purchased a new stake in shares of American Vanguard during the 1st quarter worth about $28,000. nVerses Capital LLC purchased a new stake in shares of American Vanguard during the 4th quarter worth about $42,000. Virtu Financial LLC acquired a new stake in shares of American Vanguard during the 4th quarter valued at about $52,000. Finally, Jain Global LLC acquired a new stake in shares of American Vanguard during the 4th quarter valued at about $53,000. Hedge funds and other institutional investors own 79.00% of the company's stock.
Analysts Set New Price Targets
A number of equities analysts recently commented on AVD shares. Weiss Ratings restated a "sell (e+)" rating on shares of American Vanguard in a report on Thursday, August 13th. Wall Street Zen cut shares of American Vanguard from a "hold" rating to a "sell" rating in a research note on Saturday, August 15th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, American Vanguard presently has an average rating of "Sell".
Read Our Latest Research Report on American Vanguard
American Vanguard Stock Performance
NYSE AVD opened at $2.33 on Friday. American Vanguard Corporation has a 52-week low of $2.03 and a 52-week high of $5.92. The company has a debt-to-equity ratio of 1.46, a current ratio of 2.47 and a quick ratio of 1.40. The firm has a market capitalization of $68.73 million, a price-to-earnings ratio of -1.23 and a beta of 1.43. The company's fifty day moving average is $2.50 and its two-hundred day moving average is $2.91.
American Vanguard (NYSE:AVD - Get Free Report) last posted its quarterly earnings results on Monday, August 10th. The basic materials company reported ($0.34) EPS for the quarter, missing the consensus estimate of $0.09 by ($0.43). The firm had revenue of $116.75 million during the quarter, compared to analyst estimates of $135.00 million. American Vanguard had a negative net margin of 10.70% and a negative return on equity of 9.05%.
Insider Transactions at American Vanguard
In related news, Director Steven D. Macicek acquired 19,000 shares of the firm's stock in a transaction on Monday, August 17th. The shares were bought at an average cost of $2.09 per share, with a total value of $39,710.00. Following the completion of the acquisition, the director owned 99,711 shares of the company's stock, valued at $208,395.99. This trade represents a 23.54% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Keith M. Rosenbloom sold 556,580 shares of the stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $2.20, for a total value of $1,224,476.00. Following the transaction, the director owned 15,201 shares of the company's stock, valued at $33,442.20. This represents a 97.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 5.60% of the stock is owned by company insiders.
About American Vanguard
(
Free Report)
American Vanguard Corporation NYSE: AVD is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.
The company's product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider American Vanguard, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Vanguard wasn't on the list.
While American Vanguard currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.